{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T19:58:53Z","timestamp":1719950333877},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T00:00:00Z","timestamp":1431907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ejmech.2015.05.022","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T16:51:18Z","timestamp":1431967878000},"page":"149-159","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effects of alkylation and immunopotentiation against Ehrlich ascites murine carcinoma in\u00a0vivo using novel tetra-O-acetate haloacetamido carbohydrate analogs"],"prefix":"10.1016","volume":"98","author":[{"given":"Matthew","family":"Trendowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy D.","family":"Christen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph N.","family":"Zoino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas P.","family":"Fondy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejmech.2015.05.022_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nrc3185","article-title":"Balancing repair and tolerance of DNA damage caused by alkylating agents","volume":"12","author":"Fu","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2015.05.022_bib2","series-title":"Cancer Chemotherapy and Biotherapy: Principles and Practice","author":"Chabner","year":"2011"},{"issue":"19","key":"10.1016\/j.ejmech.2015.05.022_bib3","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200011093431901","article-title":"Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents","volume":"343","author":"Esteller","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ejmech.2015.05.022_bib4","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/carcin\/21.10.1879","article-title":"Increased susceptibility to chemotherapeutic alkylating agents of mice deficient in DNA repair methyltransferase","volume":"21","author":"Shiraishi","year":"2000","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.ejmech.2015.05.022_bib5","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1074\/mcp.R900006-MCP200","article-title":"Plasma membrane proteomics and its application in clinical cancer biomarker discovery","volume":"9","author":"Leth-Larsen","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ejmech.2015.05.022_bib6","unstructured":"Kohnke PL, Mulligan SP, Christopherson RI. Membrane proteomics for leukemia classification and drug target identification. Curr. Opin. Mol. Ther.; 11(6): 603\u2013610."},{"issue":"1","key":"10.1016\/j.ejmech.2015.05.022_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2100001","article-title":"Endocytosis: a review of mechanisms and plasma membrane dynamics","volume":"210","author":"Besterman","year":"1983","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.ejmech.2015.05.022_bib8","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.devcel.2012.11.004","article-title":"ER-to-plasma membrane tethering proteins regulate cell signaling and ER morphology","volume":"23","author":"Manford","year":"2012","journal-title":"Dev. Cell."},{"issue":"19\u201320","key":"10.1016\/j.ejmech.2015.05.022_bib9","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1002\/pmic.201100519","article-title":"Advances in membrane proteomics and cancer biomarker discovery: current status and future perspective","volume":"12","author":"Shukla","year":"2012","journal-title":"Proteomics"},{"issue":"6","key":"10.1016\/j.ejmech.2015.05.022_bib10","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.devcel.2012.11.004","article-title":"ER-to-plasma membrane tethering proteins regulate cell signaling and ER morphology","volume":"23","author":"Manford","year":"2012","journal-title":"Dev. Cell."},{"issue":"12","key":"10.1016\/j.ejmech.2015.05.022_bib11","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1182\/blood.V100.12.3853","article-title":"Leukocyte extravasation: chemokine transport and presentation by the endothelium","volume":"100","author":"Middleton","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejmech.2015.05.022_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004180050387","article-title":"Molecular mechanisms that control leukocyte extravasation: the selectins and the chemokines","volume":"112","author":"Ebnet","year":"1999","journal-title":"Histochem Cell. Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2015.05.022_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/smim.2001.0344","article-title":"Selectins: critical mediators of leukocyte recruitment","volume":"14","author":"Patel","year":"2002","journal-title":"Semin. Immunol."},{"issue":"7","key":"10.1016\/j.ejmech.2015.05.022_bib14","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1021\/jm00139a016","article-title":"Haloacetamido analogues of 2-amino-2-deoxy-D-mannose. Syntheses and effects on tumor-bearing mice","volume":"24","author":"Fondy","year":"1981","journal-title":"J.\u00a0Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2015.05.022_bib15","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1021\/jm00210a010","article-title":"Haloacetamido analogues of 2-amino-2-deoxy-D-glucose and 2-amino-2-deoxy-D-galactose. Syntheses and effects on the Friend murine erythroleukemia","volume":"21","author":"Fondy","year":"1978","journal-title":"J.\u00a0Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2015.05.022_bib16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1021\/jm00215a005","article-title":"3-Fluoro-1-hydroxypropan-2-one (fluorohydroxyacetone) and some esters. Syntheses and effects in BDF mice","volume":"20","author":"Pero","year":"1977","journal-title":"J.\u00a0Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2015.05.022_bib17","first-page":"3897","article-title":"N-bromoacetyl-beta-D-glucosamine tetra-O-acetate and N-bromoacetyl-beta-D-galactosamine tetra-O-acetate as chemotherapeutic agents with immunopotentiating effects in Ehrlich ascites tumor-bearing mice","volume":"39","author":"Simon","year":"1979","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2015.05.022_bib18","unstructured":"Babiarz-Tracy P, McCarthy D, Simon P, Burlingham WJ, Fondy TP. Esters of chlorohydroxyacetone in chemotherapy of murine tumors. Cancer Res.; 40(9): 3274\u20133280."},{"key":"10.1016\/j.ejmech.2015.05.022_bib19","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1021\/ac60175a029","article-title":"Colorimetric estimation of nitrogen mustards in aqueous media","volume":"3","author":"Friedman","year":"1961","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2015.05.022_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0021-9258(18)33262-9","article-title":"The role of membranes in the mechanism of action of the antineoplastic agent adriamycin. Spin-labeling studies with chronically hypoxic and drug-resistant tumor cells","volume":"258","author":"Siegfried","year":"1983","journal-title":"J.\u00a0Biol. Chem."},{"issue":"2\u20133","key":"10.1016\/j.ejmech.2015.05.022_bib21","first-page":"217","article-title":"Membrane fluidity in Ehrlich ascites tumor cells treated with adriamycin","volume":"8","author":"Sugiyama","year":"1986","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"6","key":"10.1016\/j.ejmech.2015.05.022_bib22","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/bi00380a043","article-title":"Study of the adriamycin-cardiolipin complex structure using attenuated total reflection infrared spectroscopy","volume":"26","author":"Goormaghtigh","year":"1987","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.ejmech.2015.05.022_bib23","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/S0006-3495(98)77681-7","article-title":"Orientation of anthracyclines in lipid monolayers and planar asymmetrical bilayers: a surface-enhanced resonance Raman scattering study","volume":"75","author":"Heywang","year":"1998","journal-title":"Biophys. J."},{"issue":"4556","key":"10.1016\/j.ejmech.2015.05.022_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.7089561","article-title":"The anticancer agent adriamycin can be actively cytotoxic without entering cells","volume":"217","author":"Triton","year":"1982","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.ejmech.2015.05.022_bib25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.biopha.2004.08.006","article-title":"Oral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC)","volume":"58","author":"Nicolini","year":"2004","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2015.05.022_bib26","series-title":"The Biology of Cancer","author":"Weinberg","year":"2013"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415300490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415300490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T12:11:52Z","timestamp":1652011912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523415300490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":26,"alternative-id":["S0223523415300490"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.05.022","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of alkylation and immunopotentiation against Ehrlich ascites murine carcinoma in\u00a0vivo using novel tetra-O-acetate haloacetamido carbohydrate analogs","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}